Jennifer SVZ amyg wide.jpg


What is NeuroValida?

NeuroValida is a breakthrough drug validation platform that assists CNS drug target discovery by utilizing adult human brain tissue microarrays, automated microscopy, and high content automated image analysis. Our aim is to work with you to accelerate CNS drug discovery and allow further validation of preclinical outcomes.

Why Us?

"NeuroValida is a wonderful platform that offers us the opportunity to honour the wishes of the donor families to use their very generous gifts to pursue the boundaries of developing new treatments for brain diseases” - Sir Richard Faull.

Our Team

Our Research

NeuroValida scientists focus on neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and motor neuron disease, and have collaborated with various international partners. We have autopsy samples available for Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, motor neuron disease, epilepsy, frontotemporal dementia and glioblastoma, and have published 100’s of research papers in leading international journals in the following areas: